{"slug":"pancreatic-deep-dive","tag":"pancreatic-deep-dive","variants":["pancreatic-deep-dive"],"description":"Registry-only phase 2 and 3 trials that name pancreatic cancer in their title or conditions, recorded from ClinicalTrials.gov during the pancreatic cancer deep dive of September 2026; registry facts only, no outcomes.","count":284,"kinds":{"trial":284},"related":[],"records":[{"id":"nct06783140","kind":"trial","name":"Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer","route":"/trials/nct06783140/","status":"active","tldr":"A phase 2/3 trial of nab-paclitaxel, gemcitabine and cisplatin in pancreatic cancer, run by University Health Network, Toronto, active but no longer recruiting."},{"id":"nct06946420","kind":"trial","name":"SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy","route":"/trials/nct06946420/","status":"active","tldr":"A phase 3 trial in pancreatic cancer, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, active but no longer recruiting."},{"id":"nct05836870","kind":"trial","name":"Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer","route":"/trials/nct05836870/","status":"active","tldr":"A phase 3 trial in pancreatic cancer, run by M.D. Anderson Cancer Center, active but no longer recruiting."},{"id":"nct06115499","kind":"trial","name":"The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer","route":"/trials/nct06115499/","status":"active","tldr":"A phase 2/3 trial of nab-paclitaxel, gemcitabine and cisplatin in pancreatic cancer, run by Alliance for Clinical Trials in Oncology, active but no longer recruiting."},{"id":"nct07386704","kind":"trial","name":"Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer","route":"/trials/nct07386704/","status":"recruiting","tldr":"A phase 2 trial of nimotuzumab in pancreatic cancer, run by Peking University First Hospital, now recruiting."},{"id":"nct07344220","kind":"trial","name":"Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate","route":"/trials/nct07344220/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Hoag Memorial Hospital Presbyterian, now recruiting."},{"id":"nct06866977","kind":"trial","name":"A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer","route":"/trials/nct06866977/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by Xiangya Hospital of Central South University, not yet recruiting."},{"id":"nct07469956","kind":"trial","name":"Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer","route":"/trials/nct07469956/","status":"planned","tldr":"A phase 2 trial of surufatinib, toripalimab and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Sun Yat-sen University, not yet recruiting."},{"id":"nct07138846","kind":"trial","name":"A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer","route":"/trials/nct07138846/","status":"planned","tldr":"A phase 3 trial in pancreatic cancer, run by Lepu Biopharma Co., Ltd., not yet recruiting."},{"id":"nct07153289","kind":"trial","name":"CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)","route":"/trials/nct07153289/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by University Hospital Tuebingen, not yet recruiting."},{"id":"nct07415525","kind":"trial","name":"IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer","route":"/trials/nct07415525/","status":"planned","tldr":"A phase 2 trial of IBI343 in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct06991491","kind":"trial","name":"Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)","route":"/trials/nct06991491/","status":"planned","tldr":"A phase 2 trial of ivonescimab in pancreatic cancer, run by West China Hospital, not yet recruiting."},{"id":"nct07745790","kind":"trial","name":"Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer","route":"/trials/nct07745790/","status":"planned","tldr":"A phase 2 trial of sintilimab and tegafur, gimeracil and oteracil (S-1) in pancreatic cancer, run by Ruijin Hospital, not yet recruiting."},{"id":"nct04901741","kind":"trial","name":"Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer","route":"/trials/nct04901741/","status":"planned","tldr":"A phase 2 trial of pembrolizumab in pancreatic cancer, run by TME Pharma AG, not yet recruiting."},{"id":"nct07814066","kind":"trial","name":"A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastati","route":"/trials/nct07814066/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07705074","kind":"trial","name":"FAPI PET Imaging - An Exploratory Study","route":"/trials/nct07705074/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by Martin Huellner, not yet recruiting."},{"id":"nct07028424","kind":"trial","name":"PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment","route":"/trials/nct07028424/","status":"planned","tldr":"A phase 2 trial of liposomal irinotecan, paclitaxel / nab-paclitaxel, gemcitabine, cAPOX (capecitabine, oxaliplatin) and other drugs in pancreatic cancer, run by GERCOR - Multidisciplinary Oncology Cooperative Group, not yet recruiting."},{"id":"nct06383078","kind":"trial","name":"HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer","route":"/trials/nct06383078/","status":"planned","tldr":"A phase 2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), tegafur, gimeracil and oteracil (S-1), leucovorin (folinic acid) and other drugs in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting."},{"id":"nct07277452","kind":"trial","name":"Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer","route":"/trials/nct07277452/","status":"planned","tldr":"A phase 2 trial of nimotuzumab and gemcitabine + nab-paclitaxel in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting."},{"id":"nct07477418","kind":"trial","name":"PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)","route":"/trials/nct07477418/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by University of Vermont, not yet recruiting."},{"id":"nct06759090","kind":"trial","name":"Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer","route":"/trials/nct06759090/","status":"planned","tldr":"A phase 2 trial of camrelizumab in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct06513455","kind":"trial","name":"Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer","route":"/trials/nct06513455/","status":"planned","tldr":"A phase 1/2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Harbin Medical University, not yet recruiting."},{"id":"nct05810792","kind":"trial","name":"Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer","route":"/trials/nct05810792/","status":"planned","tldr":"A phase 2 trial of histamine dihydrochloride and aldesleukin (high-dose IL-2) in pancreatic cancer, run by Sahlgrenska University Hospital, not yet recruiting."},{"id":"nct07765836","kind":"trial","name":"Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC","route":"/trials/nct07765836/","status":"planned","tldr":"A phase 2 trial of retifanlimab in pancreatic cancer, run by Massachusetts General Hospital, not yet recruiting."},{"id":"nct07230301","kind":"trial","name":"Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions","route":"/trials/nct07230301/","status":"planned","tldr":"A phase 2 trial of adebrelimab in pancreatic cancer, run by Sizhen Wang, not yet recruiting."},{"id":"nct07773363","kind":"trial","name":"Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer","route":"/trials/nct07773363/","status":"planned","tldr":"A phase 2 trial of retlirafusp alfa and rivoceranib (apatinib) in pancreatic cancer, run by Tang-Du Hospital, not yet recruiting."},{"id":"nct06573398","kind":"trial","name":"Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC","route":"/trials/nct06573398/","status":"planned","tldr":"A phase 2 trial of tislelizumab in pancreatic cancer, run by Ruijin Hospital, not yet recruiting."},{"id":"nct07691593","kind":"trial","name":"Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer","route":"/trials/nct07691593/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Changhai Hospital, not yet recruiting."},{"id":"nct06233877","kind":"trial","name":"Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer","route":"/trials/nct06233877/","status":"planned","tldr":"A phase 2 trial of mitomycin C in pancreatic cancer, run by Hirschfeld Oncology, not yet recruiting."},{"id":"nct06750861","kind":"trial","name":"QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC","route":"/trials/nct06750861/","status":"planned","tldr":"A phase 2 trial of iparomlimab and tuvonralimab in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07689539","kind":"trial","name":"Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation","route":"/trials/nct07689539/","status":"planned","tldr":"A phase 3 trial in pancreatic cancer, run by Jiangxi Kvvit Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06370754","kind":"trial","name":"Newly Emerging Immunotherapy for Pancreatic Cancer Treatment","route":"/trials/nct06370754/","status":"planned","tldr":"A phase 1/2 trial of liposomal irinotecan, fluorouracil (5-FU), fLOT (5-FU, leucovorin, oxaliplatin, docetaxel), nab-paclitaxel and other drugs in pancreatic cancer, run by Fudan University, not yet recruiting."},{"id":"nct07578337","kind":"trial","name":"A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.","route":"/trials/nct07578337/","status":"planned","tldr":"A phase 2 trial of gemcitabine, nab-paclitaxel and botensilimab in pancreatic cancer, run by Nelum Corp, not yet recruiting."},{"id":"nct06621095","kind":"trial","name":"Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)","route":"/trials/nct06621095/","status":"planned","tldr":"A phase 2 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by RenJi Hospital, not yet recruiting."},{"id":"nct06009029","kind":"trial","name":"SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)","route":"/trials/nct06009029/","status":"planned","tldr":"A phase 2 trial of zimberelimab in pancreatic cancer, run by Peking University Third Hospital, not yet recruiting."},{"id":"nct03301805","kind":"trial","name":"A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer","route":"/trials/nct03301805/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Rgene Corporation, not yet recruiting."},{"id":"nct06166589","kind":"trial","name":"Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer","route":"/trials/nct06166589/","status":"planned","tldr":"A phase 2 trial of zimberelimab, cAPOX (capecitabine, oxaliplatin), tegafur, gimeracil and oteracil (S-1) and fOLFIRI (5-FU, leucovorin, irinotecan) in pancreatic cancer, run by Shanghai Zhongshan Hospital, not yet recruiting."},{"id":"nct06255912","kind":"trial","name":"Clinical Trial for Advanced or Metastatic Pancreatic Cancer","route":"/trials/nct06255912/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07705919","kind":"trial","name":"DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer","route":"/trials/nct07705919/","status":"planned","tldr":"A phase 1/2 trial of fluorouracil (5-FU), gemcitabine, fOLFIRI (5-FU, leucovorin, irinotecan), leucovorin (folinic acid) and other drugs in pancreatic cancer, run by Ohio State University Comprehensive Cancer Center, not yet recruiting."},{"id":"nct06361030","kind":"trial","name":"Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer","route":"/trials/nct06361030/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, not yet recruiting."},{"id":"nct07711067","kind":"trial","name":"A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer","route":"/trials/nct07711067/","status":"planned","tldr":"A phase 2/3 trial in pancreatic cancer, run by ElmediX, not yet recruiting."},{"id":"nct07670312","kind":"trial","name":"Evaluation of XYA02 in Patients With Advanced Solid Tumors","route":"/trials/nct07670312/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by XYone Therapeutics, Inc, not yet recruiting."},{"id":"nct07336953","kind":"trial","name":"A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic P","route":"/trials/nct07336953/","status":"planned","tldr":"A phase 3 trial of gemcitabine + nab-paclitaxel and serplulimab in pancreatic cancer, run by West China Hospital, not yet recruiting."},{"id":"nct07678593","kind":"trial","name":"A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation","route":"/trials/nct07678593/","status":"planned","tldr":"A phase 1/2 trial of cetuximab, nab-paclitaxel, gemcitabine, fluorouracil (5-FU) and other drugs in pancreatic cancer, run by Genfleet Therapeutics (Shanghai) Inc., not yet recruiting."},{"id":"nct07802184","kind":"trial","name":"GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDAC","route":"/trials/nct07802184/","status":"planned","tldr":"A phase 1/2 trial of retlirafusp alfa, rivoceranib (apatinib), gemcitabine and nab-paclitaxel in pancreatic cancer, run by West China Hospital, not yet recruiting."},{"id":"nct07333287","kind":"trial","name":"A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Emboli","route":"/trials/nct07333287/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Shandong Provincial Hospital, not yet recruiting."},{"id":"nct07824960","kind":"trial","name":"Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic Adenocarcinoma","route":"/trials/nct07824960/","status":"planned","tldr":"A phase 1/2 trial of avutometinib + defactinib in pancreatic cancer, run by University of Virginia, not yet recruiting."},{"id":"nct07175389","kind":"trial","name":"JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure","route":"/trials/nct07175389/","status":"planned","tldr":"A phase 1/2 trial of serplulimab in pancreatic cancer, run by West China Hospital, not yet recruiting."},{"id":"nct07342725","kind":"trial","name":"Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Met","route":"/trials/nct07342725/","status":"planned","tldr":"A phase 1/2 trial of IBI363 in pancreatic cancer, run by Ruijin Hospital, not yet recruiting."},{"id":"nct05637567","kind":"trial","name":"Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head","route":"/trials/nct05637567/","status":"planned","tldr":"A phase 2 trial of aspirin in pancreatic cancer, run by German Cancer Research Center, not yet recruiting."},{"id":"nct06888648","kind":"trial","name":"Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.","route":"/trials/nct06888648/","status":"planned","tldr":"A phase 1/2 trial of sintilimab in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct06571461","kind":"trial","name":"Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Canc","route":"/trials/nct06571461/","status":"planned","tldr":"A phase 3 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), tegafur, gimeracil and oteracil (S-1), gemcitabine and other drugs in pancreatic cancer, run by CSPC Ouyi Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06662669","kind":"trial","name":"YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer","route":"/trials/nct06662669/","status":"planned","tldr":"A phase 1/2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Shanghai YingLi Pharmaceutical Co. Ltd., not yet recruiting."},{"id":"nct05562297","kind":"trial","name":"Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer","route":"/trials/nct05562297/","status":"planned","tldr":"A phase 2 trial of sintilimab, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Shanghai Zhongshan Hospital, not yet recruiting."},{"id":"nct06999512","kind":"trial","name":"Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for C","route":"/trials/nct06999512/","status":"planned","tldr":"A phase 2/3 trial in pancreatic cancer, run by Assistance Publique - Hôpitaux de Paris, not yet recruiting."},{"id":"nct05988372","kind":"trial","name":"Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)","route":"/trials/nct05988372/","status":"planned","tldr":"A phase 2 trial of surufatinib, serplulimab and gemcitabine in pancreatic cancer, run by Sun Yat-sen University, not yet recruiting."},{"id":"nct07827053","kind":"trial","name":"Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer","route":"/trials/nct07827053/","status":"planned","tldr":"A phase 2 trial of adebrelimab and nALIRIFOX (liposomal irinotecan + oxaliplatin + 5-FU/LV) in pancreatic cancer, run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, not yet recruiting."},{"id":"nct07748611","kind":"trial","name":"SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial","route":"/trials/nct07748611/","status":"planned","tldr":"A phase 2 trial of fluorouracil (5-FU), gemcitabine, fOLFIRI (5-FU, leucovorin, irinotecan), fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) and other drugs in pancreatic cancer, run by Northwestern University, not yet recruiting."},{"id":"nct07689955","kind":"trial","name":"A Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic Cancer","route":"/trials/nct07689955/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Royal Marsden NHS Foundation Trust, not yet recruiting."},{"id":"nct07698613","kind":"trial","name":"EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer","route":"/trials/nct07698613/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by Brown University, not yet recruiting."},{"id":"nct07561463","kind":"trial","name":"Sacituzumab Tirumotecan for Pancreatic Cancer","route":"/trials/nct07561463/","status":"planned","tldr":"A phase 2 trial of sacituzumab tirumotecan in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07504263","kind":"trial","name":"Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies","route":"/trials/nct07504263/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by Recurv Pharma Inc, not yet recruiting."},{"id":"nct07631871","kind":"trial","name":"An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy","route":"/trials/nct07631871/","status":"planned","tldr":"A phase 2 trial of zanidatamab in pancreatic cancer, run by Haihua Yuan, not yet recruiting."},{"id":"nct06329947","kind":"trial","name":"A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD","route":"/trials/nct06329947/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Rui-hua Xu, MD, PhD, not yet recruiting."},{"id":"nct07155629","kind":"trial","name":"Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer","route":"/trials/nct07155629/","status":"planned","tldr":"A phase 3 trial in pancreatic cancer, run by Helsinki University Central Hospital, not yet recruiting."},{"id":"nct06259058","kind":"trial","name":"Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer","route":"/trials/nct06259058/","status":"planned","tldr":"A phase 1/2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct06172036","kind":"trial","name":"Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab","route":"/trials/nct06172036/","status":"planned","tldr":"A phase 2 trial of cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and leucovorin (folinic acid) in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct06492941","kind":"trial","name":"A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer","route":"/trials/nct06492941/","status":"planned","tldr":"A phase 3 trial in pancreatic cancer, run by CSPC ZhongQi Pharmaceutical Technology Co., Ltd., not yet recruiting."},{"id":"nct04381130","kind":"trial","name":"A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer","route":"/trials/nct04381130/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by Everfront Biotech Co., Ltd., not yet recruiting."},{"id":"nct06916975","kind":"trial","name":"Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer","route":"/trials/nct06916975/","status":"planned","tldr":"A phase 2 trial of adebrelimab in pancreatic cancer, run by Jin Xu, not yet recruiting."},{"id":"nct06217042","kind":"trial","name":"HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer","route":"/trials/nct06217042/","status":"planned","tldr":"A phase 3 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), leucovorin (folinic acid), gemcitabine and other drugs in pancreatic cancer, run by Fudan University, not yet recruiting."},{"id":"nct06210360","kind":"trial","name":"Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX","route":"/trials/nct06210360/","status":"planned","tldr":"A phase 2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and leucovorin (folinic acid) in pancreatic cancer, run by Changhai Hospital, not yet recruiting."},{"id":"nct06669078","kind":"trial","name":"NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer","route":"/trials/nct06669078/","status":"planned","tldr":"A phase 2 trial of fluorouracil (5-FU) in pancreatic cancer, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, not yet recruiting."},{"id":"nct07683221","kind":"trial","name":"SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer","route":"/trials/nct07683221/","status":"planned","tldr":"A phase 2 trial of sintilimab and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Shandong Cancer Hospital and Institute, not yet recruiting."},{"id":"nct06234072","kind":"trial","name":"Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients","route":"/trials/nct06234072/","status":"planned","tldr":"A phase 2 trial of gemcitabine in pancreatic cancer, run by Shenzhen University General Hospital, not yet recruiting."},{"id":"nct06177522","kind":"trial","name":"Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer","route":"/trials/nct06177522/","status":"planned","tldr":"A phase 2 trial of adebrelimab, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Jinling Hospital, China, not yet recruiting."},{"id":"nct07806058","kind":"trial","name":"An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors","route":"/trials/nct07806058/","status":"planned","tldr":"A phase 1/2 trial of adebrelimab in pancreatic cancer, run by Jiangsu HengRui Medicine Co., Ltd., not yet recruiting."},{"id":"nct06700603","kind":"trial","name":"Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer","route":"/trials/nct06700603/","status":"planned","tldr":"A phase 2 trial of fluorouracil (5-FU) in pancreatic cancer, run by Rui-hua Xu, MD, PhD, not yet recruiting."},{"id":"nct07814859","kind":"trial","name":"Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer","route":"/trials/nct07814859/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by The First Affiliated Hospital of Zhengzhou University, not yet recruiting."},{"id":"nct07097064","kind":"trial","name":"Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers","route":"/trials/nct07097064/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Institut du Cancer de Montpellier - Val d'Aurelle, not yet recruiting."},{"id":"nct07233850","kind":"trial","name":"A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers","route":"/trials/nct07233850/","status":"planned","tldr":"A phase 2 trial of SSGJ-706, cAPOX (capecitabine, oxaliplatin) and bevacizumab in pancreatic cancer, run by Shenyang Sunshine Pharmaceutical Co., LTD., not yet recruiting."},{"id":"nct07825753","kind":"trial","name":"Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer","route":"/trials/nct07825753/","status":"planned","tldr":"A phase 2 trial of trastuzumab emtansine, trastuzumab deruxtecan, datopotamab deruxtecan, sacituzumab govitecan and other drugs in pancreatic cancer, run by Fudan University, not yet recruiting."},{"id":"nct07752875","kind":"trial","name":"A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation","route":"/trials/nct07752875/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by LG Chem, not yet recruiting."},{"id":"nct06938503","kind":"trial","name":"AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer","route":"/trials/nct06938503/","status":"planned","tldr":"A phase 2 trial of gemcitabine + nab-paclitaxel and nimotuzumab in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct07446270","kind":"trial","name":"Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies","route":"/trials/nct07446270/","status":"planned","tldr":"A phase 2 trial of cetuximab and nimotuzumab in pancreatic cancer, run by Chinese PLA General Hospital, not yet recruiting."},{"id":"nct07108504","kind":"trial","name":"Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer","route":"/trials/nct07108504/","status":"planned","tldr":"A phase 2 trial of gemcitabine and LM-302 in pancreatic cancer, run by Shanghai Zhongshan Hospital, not yet recruiting."},{"id":"nct06888674","kind":"trial","name":"Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.","route":"/trials/nct06888674/","status":"planned","tldr":"A phase 1/2 trial of gemcitabine, capecitabine and sintilimab in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct07208539","kind":"trial","name":"AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.","route":"/trials/nct07208539/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Shanghai Zhongshan Hospital, not yet recruiting."},{"id":"nct06409429","kind":"trial","name":"Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer","route":"/trials/nct06409429/","status":"planned","tldr":"A phase 2/3 trial of nimotuzumab in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct07736612","kind":"trial","name":"A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer","route":"/trials/nct07736612/","status":"planned","tldr":"A phase 1/2 trial of nimotuzumab, HS-20093 and adebrelimab in pancreatic cancer, run by Zhejiang University, not yet recruiting."},{"id":"nct07784374","kind":"trial","name":"A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metast","route":"/trials/nct07784374/","status":"planned","tldr":"A phase 2 trial of GFH375 in pancreatic cancer, run by Genfleet Therapeutics (Shanghai) Inc., not yet recruiting."},{"id":"nct07802418","kind":"trial","name":"Molecularly Tailored Therapy in Advanced Pancreatic Cancer","route":"/trials/nct07802418/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Herlev Hospital, not yet recruiting."},{"id":"nct07803783","kind":"trial","name":"A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based","route":"/trials/nct07803783/","status":"planned","tldr":"A phase 3 trial of YL201, liposomal irinotecan, fluorouracil (5-FU) and fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) in pancreatic cancer, run by MediLink Therapeutics (Suzhou) Co., Ltd., not yet recruiting."},{"id":"nct07665684","kind":"trial","name":"Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer","route":"/trials/nct07665684/","status":"planned","tldr":"A phase 1/2 trial in pancreatic cancer, run by University Health Network, Toronto, not yet recruiting."},{"id":"nct07828756","kind":"trial","name":"Albumin-bound Paclitaxel (II)-Combined Regimens for Pancreatic Cancer","route":"/trials/nct07828756/","status":"planned","tldr":"A phase 2 trial of cisplatin, nab-paclitaxel, capecitabine and gemcitabine in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct07383922","kind":"trial","name":"A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer","route":"/trials/nct07383922/","status":"planned","tldr":"A phase 3 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by FutureGen Biopharmaceutical (Beijing) Co., Ltd, not yet recruiting."},{"id":"nct07429643","kind":"trial","name":"Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.","route":"/trials/nct07429643/","status":"planned","tldr":"A phase 2/3 trial in pancreatic cancer, run by Assiut University, not yet recruiting."},{"id":"nct07831330","kind":"trial","name":"Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer","route":"/trials/nct07831330/","status":"planned","tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting."},{"id":"nct07656376","kind":"trial","name":"Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation","route":"/trials/nct07656376/","status":"planned","tldr":"A phase 2/3 trial in pancreatic cancer, run by Jiangxi Kvvit Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07301229","kind":"trial","name":"A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer","route":"/trials/nct07301229/","status":"planned","tldr":"A phase 2 trial in pancreatic cancer, run by Shanghai Henlius Biotech, not yet recruiting."},{"id":"nct07833241","kind":"trial","name":"Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC","route":"/trials/nct07833241/","status":"planned","tldr":"A phase 2 trial of gemcitabine + nab-paclitaxel, gemcitabine, capecitabine and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Shanghai Zhongshan Hospital, not yet recruiting."},{"id":"nct07272109","kind":"trial","name":"Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes","route":"/trials/nct07272109/","status":"planned","tldr":"A phase 3 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, not yet recruiting."},{"id":"nct06196671","kind":"trial","name":"Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer","route":"/trials/nct06196671/","status":"planned","tldr":"A phase 2 trial of h101 oncolytic adenovirus and camrelizumab in pancreatic cancer, run by Fudan University, not yet recruiting."},{"id":"nct06587061","kind":"trial","name":"HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","route":"/trials/nct06587061/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Ruijin Hospital, now recruiting."},{"id":"nct06423326","kind":"trial","name":"Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer","route":"/trials/nct06423326/","status":"recruiting","tldr":"A phase 2 trial of cisplatin, gemcitabine and nab-paclitaxel in pancreatic cancer, run by Emory University, now recruiting."},{"id":"nct06483555","kind":"trial","name":"Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel","route":"/trials/nct06483555/","status":"recruiting","tldr":"A phase 1/2 trial of gemcitabine, nab-paclitaxel, erlotinib, nALIRIFOX (liposomal irinotecan + oxaliplatin + 5-FU/LV) and other drugs in pancreatic cancer, run by UNC Lineberger Comprehensive Cancer Center, now recruiting."},{"id":"nct07043270","kind":"trial","name":"24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC","route":"/trials/nct07043270/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine + nab-paclitaxel and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Dartmouth-Hitchcock Medical Center, now recruiting."},{"id":"nct06938282","kind":"trial","name":"An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer","route":"/trials/nct06938282/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Shanghai Zhongshan Hospital, now recruiting."},{"id":"nct04084496","kind":"trial","name":"mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients","route":"/trials/nct04084496/","status":"recruiting","tldr":"A phase 2 trial of fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct06411795","kind":"trial","name":"Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy","route":"/trials/nct06411795/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Masonic Cancer Center, University of Minnesota, now recruiting."},{"id":"nct07235930","kind":"trial","name":"Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer","route":"/trials/nct07235930/","status":"recruiting","tldr":"A phase 3 trial of bevacizumab and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Zhejiang Cancer Hospital, now recruiting."},{"id":"nct07542002","kind":"trial","name":"Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pan","route":"/trials/nct07542002/","status":"recruiting","tldr":"A phase 2 trial of fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) and cAPOX (capecitabine, oxaliplatin) in pancreatic cancer, run by Ningbo Medical Center Lihuili Hospital, now recruiting."},{"id":"nct03322995","kind":"trial","name":"Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial","route":"/trials/nct03322995/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Medical College of Wisconsin, now recruiting."},{"id":"nct06782932","kind":"trial","name":"Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer","route":"/trials/nct06782932/","status":"recruiting","tldr":"A phase 1/2 trial of balstilimab and cyclophosphamide in pancreatic cancer, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, now recruiting."},{"id":"nct07155525","kind":"trial","name":"Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas","route":"/trials/nct07155525/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Minia University, now recruiting."},{"id":"nct04683315","kind":"trial","name":"PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples","route":"/trials/nct04683315/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Medical College of Wisconsin, now recruiting."},{"id":"nct07769502","kind":"trial","name":"A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatob","route":"/trials/nct07769502/","status":"recruiting","tldr":"A phase 2 trial of telisotuzumab adizutecan, gemcitabine and nab-paclitaxel in pancreatic cancer, run by AbbVie, now recruiting."},{"id":"nct07632118","kind":"trial","name":"Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery","route":"/trials/nct07632118/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting."},{"id":"nct05841420","kind":"trial","name":"Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer","route":"/trials/nct05841420/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Morten Ladekarl, now recruiting."},{"id":"nct07595835","kind":"trial","name":"CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer","route":"/trials/nct07595835/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by M.R. Meijerink, now recruiting."},{"id":"nct04172532","kind":"trial","name":"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","route":"/trials/nct04172532/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct05438459","kind":"trial","name":"GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites","route":"/trials/nct05438459/","status":"recruiting","tldr":"A phase 1/2 trial of pembrolizumab, trifluridine/tipiracil and fluorouracil (5-FU) in pancreatic cancer, run by Kyushu University, now recruiting."},{"id":"nct07410676","kind":"trial","name":"EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors","route":"/trials/nct07410676/","status":"recruiting","tldr":"A phase 1/2 trial of pembrolizumab in pancreatic cancer, run by Essen Biotech, now recruiting."},{"id":"nct05679583","kind":"trial","name":"Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer","route":"/trials/nct05679583/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Yonsei University, now recruiting."},{"id":"nct07483983","kind":"trial","name":"Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Bi","route":"/trials/nct07483983/","status":"recruiting","tldr":"A phase 2 trial of setidegrasib in pancreatic cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct07066995","kind":"trial","name":"Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer","route":"/trials/nct07066995/","status":"recruiting","tldr":"A phase 1/2 trial of EB-MF-CAR-NK-01 in pancreatic cancer, run by Essen Biotech, now recruiting."},{"id":"nct07440290","kind":"trial","name":"DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positi","route":"/trials/nct07440290/","status":"recruiting","tldr":"A phase 2/3 trial of dabrafenib and trametinib in pancreatic cancer, run by Cancer Research UK, now recruiting."},{"id":"nct06906562","kind":"trial","name":"A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic","route":"/trials/nct06906562/","status":"recruiting","tldr":"A phase 2 trial of pemigatinib in pancreatic cancer, run by Sameek Roychowdhury, now recruiting."},{"id":"nct07353645","kind":"trial","name":"KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer","route":"/trials/nct07353645/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, now recruiting."},{"id":"nct06843551","kind":"trial","name":"The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation","route":"/trials/nct06843551/","status":"recruiting","tldr":"A phase 2 trial of botensilimab and balstilimab in pancreatic cancer, run by Benjamin Spieler, now recruiting."},{"id":"nct06790602","kind":"trial","name":"Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma","route":"/trials/nct06790602/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by University of California, San Diego, now recruiting."},{"id":"nct07312422","kind":"trial","name":"LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study","route":"/trials/nct07312422/","status":"recruiting","tldr":"A phase 1/2 trial of pucotenlimab and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Zhejiang Provincial People's Hospital, now recruiting."},{"id":"nct06427239","kind":"trial","name":"Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma","route":"/trials/nct06427239/","status":"recruiting","tldr":"A phase 1/2 trial of adebrelimab and SHR-8068 in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06782412","kind":"trial","name":"Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Dif","route":"/trials/nct06782412/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by KU Leuven, now recruiting."},{"id":"nct06391892","kind":"trial","name":"Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery","route":"/trials/nct06391892/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Elisabethinen Hospital, now recruiting."},{"id":"nct06095141","kind":"trial","name":"Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency","route":"/trials/nct06095141/","status":"recruiting","tldr":"A phase 2/3 trial of cisplatin in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06861452","kind":"trial","name":"Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma","route":"/trials/nct06861452/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by EIR Biotherapies s.r.l., now recruiting."},{"id":"nct05187338","kind":"trial","name":"Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors","route":"/trials/nct05187338/","status":"recruiting","tldr":"A phase 1/2 trial of ipilimumab, pembrolizumab and durvalumab in pancreatic cancer, run by Second Affiliated Hospital of Guangzhou Medical University, now recruiting."},{"id":"nct06159478","kind":"trial","name":"Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)","route":"/trials/nct06159478/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by National Cancer Center, Japan, now recruiting."},{"id":"nct05821556","kind":"trial","name":"Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients","route":"/trials/nct05821556/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel, cisplatin and capecitabine in pancreatic cancer, run by National Cancer Institute, Naples, now recruiting."},{"id":"nct06736717","kind":"trial","name":"Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer","route":"/trials/nct06736717/","status":"recruiting","tldr":"A phase 1/2 trial of onvansertib and nALIRIFOX (liposomal irinotecan + oxaliplatin + 5-FU/LV) in pancreatic cancer, run by University of Kansas Medical Center, now recruiting."},{"id":"nct06844422","kind":"trial","name":"Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)","route":"/trials/nct06844422/","status":"recruiting","tldr":"A phase 1/2 trial of ivonescimab in pancreatic cancer, run by Shandong Cancer Hospital and Institute, now recruiting."},{"id":"nct05218889","kind":"trial","name":"Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer","route":"/trials/nct05218889/","status":"recruiting","tldr":"A phase 1/2 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by Chinese PLA General Hospital, now recruiting."},{"id":"nct07436741","kind":"trial","name":"Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable P","route":"/trials/nct07436741/","status":"recruiting","tldr":"A phase 3 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting."},{"id":"nct06384560","kind":"trial","name":"Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)","route":"/trials/nct06384560/","status":"recruiting","tldr":"A phase 1/2 trial of pembrolizumab and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Amsterdam UMC, location VUmc, now recruiting."},{"id":"nct06199895","kind":"trial","name":"Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholan","route":"/trials/nct06199895/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Liu Huang, now recruiting."},{"id":"nct06580002","kind":"trial","name":"Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial","route":"/trials/nct06580002/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by University of California, Irvine, now recruiting."},{"id":"nct07285044","kind":"trial","name":"The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients","route":"/trials/nct07285044/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct06479239","kind":"trial","name":"Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer","route":"/trials/nct06479239/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by University of Virginia, now recruiting."},{"id":"nct07040228","kind":"trial","name":"A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer","route":"/trials/nct07040228/","status":"recruiting","tldr":"A phase 1/2 trial of regorafenib and toripalimab in pancreatic cancer, run by Junjie Hang, now recruiting."},{"id":"nct06831136","kind":"trial","name":"Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma","route":"/trials/nct06831136/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by The University of Texas Health Science Center, Houston, now recruiting."},{"id":"nct06453486","kind":"trial","name":"A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment","route":"/trials/nct06453486/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by University Health Network, Toronto, now recruiting."},{"id":"nct05988814","kind":"trial","name":"Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Li","route":"/trials/nct05988814/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Centre Georges Francois Leclerc, now recruiting."},{"id":"nct07269626","kind":"trial","name":"PULSAR in Systemic Therapy for Pancreatic Cancer","route":"/trials/nct07269626/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Samsung Medical Center, now recruiting."},{"id":"nct07199764","kind":"trial","name":"Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer","route":"/trials/nct07199764/","status":"recruiting","tldr":"A phase 2 trial of mitazalimab in pancreatic cancer, run by University of Pennsylvania, now recruiting."},{"id":"nct07098598","kind":"trial","name":"Pancreatic Cancer Diagnosis With FAPI-PET Imaging","route":"/trials/nct07098598/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by Turku University Hospital, now recruiting."},{"id":"nct05929885","kind":"trial","name":"Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients","route":"/trials/nct05929885/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by National Cancer Centre, Singapore, now recruiting."},{"id":"nct07306286","kind":"trial","name":"Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy","route":"/trials/nct07306286/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Ruijin Hospital, now recruiting."},{"id":"nct06722911","kind":"trial","name":"Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer","route":"/trials/nct06722911/","status":"recruiting","tldr":"A phase 2 trial of nimotuzumab in pancreatic cancer, run by Zhejiang Provincial People's Hospital, now recruiting."},{"id":"nct06584227","kind":"trial","name":"Adebrelimab and Chidamide for Pancreatic Cancer","route":"/trials/nct06584227/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab and gemcitabine in pancreatic cancer, run by Liu Xiufeng, now recruiting."},{"id":"nct06332274","kind":"trial","name":"tislelizUMaB in canceR Patients With molEcuLar residuaL Disease","route":"/trials/nct06332274/","status":"recruiting","tldr":"A phase 3 trial of tislelizumab in pancreatic cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct05944237","kind":"trial","name":"HTL0039732 in Participants With Advanced Solid Tumours","route":"/trials/nct05944237/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Cancer Research UK, now recruiting."},{"id":"nct07595172","kind":"trial","name":"NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer","route":"/trials/nct07595172/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by West China Hospital, now recruiting."},{"id":"nct06030622","kind":"trial","name":"Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer","route":"/trials/nct06030622/","status":"recruiting","tldr":"A phase 1/2 trial of gemcitabine in pancreatic cancer, run by State University of New York - Downstate Medical Center, now recruiting."},{"id":"nct06662006","kind":"trial","name":"Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic","route":"/trials/nct06662006/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, now recruiting."},{"id":"nct05518903","kind":"trial","name":"Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma","route":"/trials/nct05518903/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct06601283","kind":"trial","name":"Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer","route":"/trials/nct06601283/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06756074","kind":"trial","name":"Reinforced Pancreaticojejunostomy With or Without glubran2","route":"/trials/nct06756074/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Minia University, now recruiting."},{"id":"nct05969860","kind":"trial","name":"At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer","route":"/trials/nct05969860/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct06435260","kind":"trial","name":"Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer","route":"/trials/nct06435260/","status":"recruiting","tldr":"A phase 2 trial of camrelizumab in pancreatic cancer, run by Hebei Medical University Fourth Hospital, now recruiting."},{"id":"nct07600268","kind":"trial","name":"Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer","route":"/trials/nct07600268/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Shandong Cancer Hospital and Institute, now recruiting."},{"id":"nct07435038","kind":"trial","name":"Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","route":"/trials/nct07435038/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Betta Pharmaceuticals Co., Ltd., now recruiting."},{"id":"nct06714604","kind":"trial","name":"Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC","route":"/trials/nct06714604/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Sahlgrenska University Hospital, now recruiting."},{"id":"nct06503146","kind":"trial","name":"18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection","route":"/trials/nct06503146/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct07110064","kind":"trial","name":"QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer","route":"/trials/nct07110064/","status":"recruiting","tldr":"A phase 2 trial of iparomlimab and tuvonralimab, lenvatinib and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Du Juan, now recruiting."},{"id":"nct07716228","kind":"trial","name":"Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein","route":"/trials/nct07716228/","status":"recruiting","tldr":"A phase 3 trial of dexamethasone in pancreatic cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting."},{"id":"nct05744219","kind":"trial","name":"Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial","route":"/trials/nct05744219/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Jon Unosson, now recruiting."},{"id":"nct05093231","kind":"trial","name":"Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer","route":"/trials/nct05093231/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab and olaparib in pancreatic cancer, run by Cambridge University Hospitals NHS Foundation Trust, now recruiting."},{"id":"nct05065801","kind":"trial","name":"Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients","route":"/trials/nct05065801/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Institut du Cancer de Montpellier - Val d'Aurelle, now recruiting."},{"id":"nct05268692","kind":"trial","name":"Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP","route":"/trials/nct05268692/","status":"recruiting","tldr":"A phase 2/3 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by Kochi University, now recruiting."},{"id":"nct04990609","kind":"trial","name":"EUS-RFA PANCARDINAL-1 Trial","route":"/trials/nct04990609/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by The University of Texas Health Science Center, Houston, now recruiting."},{"id":"nct07131514","kind":"trial","name":"HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","route":"/trials/nct07131514/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab in pancreatic cancer, run by Ruijin Hospital, now recruiting."},{"id":"nct03492671","kind":"trial","name":"Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer","route":"/trials/nct03492671/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel in pancreatic cancer, run by Loma Linda University, now recruiting."},{"id":"nct06758544","kind":"trial","name":"A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer","route":"/trials/nct06758544/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Guangdong Provincial People's Hospital, now recruiting."},{"id":"nct05969171","kind":"trial","name":"A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Ca","route":"/trials/nct05969171/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06944106","kind":"trial","name":"A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer","route":"/trials/nct06944106/","status":"recruiting","tldr":"A phase 2 trial of ivonescimab in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting."},{"id":"nct06946901","kind":"trial","name":"The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a","route":"/trials/nct06946901/","status":"recruiting","tldr":"A phase 2 trial of cisplatin in pancreatic cancer, run by Shanghai Zhongshan Hospital, now recruiting."},{"id":"nct03977233","kind":"trial","name":"Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer","route":"/trials/nct03977233/","status":"recruiting","tldr":"A phase 2 trial of cAPOX (capecitabine, oxaliplatin), fLOT (5-FU, leucovorin, oxaliplatin, docetaxel), irinotecan (and liposomal irinotecan) and fluorouracil (5-FU) in pancreatic cancer, run by UNC Lineberger Comprehensive Cancer Center, now recruiting."},{"id":"nct07504471","kind":"trial","name":"Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metast","route":"/trials/nct07504471/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Ruijin Hospital, now recruiting."},{"id":"nct06782685","kind":"trial","name":"Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV","route":"/trials/nct06782685/","status":"recruiting","tldr":"A phase 1/2 trial of cAPOX (capecitabine, oxaliplatin), bevacizumab, fluorouracil (5-FU) and leucovorin (folinic acid) in pancreatic cancer, run by Dai, Guanghai, now recruiting."},{"id":"nct06017284","kind":"trial","name":"Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer","route":"/trials/nct06017284/","status":"recruiting","tldr":"A phase 3 trial of thalidomide, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct05053971","kind":"trial","name":"Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors","route":"/trials/nct05053971/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct03498326","kind":"trial","name":"Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer","route":"/trials/nct03498326/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine in pancreatic cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting."},{"id":"nct06998940","kind":"trial","name":"Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations","route":"/trials/nct06998940/","status":"recruiting","tldr":"A phase 3 trial of fluorouracil (5-FU), gemcitabine, fOLFIRI (5-FU, leucovorin, irinotecan), fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) and other drugs in pancreatic cancer, run by SWOG Cancer Research Network, now recruiting."},{"id":"nct07410494","kind":"trial","name":"Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors","route":"/trials/nct07410494/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Essen Biotech, now recruiting."},{"id":"nct04485286","kind":"trial","name":"Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury","route":"/trials/nct04485286/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Massachusetts General Hospital, now recruiting."},{"id":"nct03608631","kind":"trial","name":"iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation","route":"/trials/nct03608631/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct07306273","kind":"trial","name":"IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy","route":"/trials/nct07306273/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Ruijin Hospital, now recruiting."},{"id":"nct06598033","kind":"trial","name":"Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer","route":"/trials/nct06598033/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06770452","kind":"trial","name":"HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients","route":"/trials/nct06770452/","status":"recruiting","tldr":"A phase 2 trial of nimotuzumab and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Zhejiang University, now recruiting."},{"id":"nct06405490","kind":"trial","name":"NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC","route":"/trials/nct06405490/","status":"recruiting","tldr":"A phase 2 trial of cAPOX (capecitabine, oxaliplatin), capecitabine and cadonilimab in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct07230509","kind":"trial","name":"Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate","route":"/trials/nct07230509/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Minia University, now recruiting."},{"id":"nct04858334","kind":"trial","name":"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a","route":"/trials/nct04858334/","status":"recruiting","tldr":"A phase 2 trial of olaparib in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct06958328","kind":"trial","name":"Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer","route":"/trials/nct06958328/","status":"recruiting","tldr":"A phase 3 trial of capecitabine, fluorouracil (5-FU), gemcitabine, irinotecan (and liposomal irinotecan) and other drugs in pancreatic cancer, run by NRG Oncology, now recruiting."},{"id":"nct06250972","kind":"trial","name":"Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer","route":"/trials/nct06250972/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct07283705","kind":"trial","name":"A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer","route":"/trials/nct07283705/","status":"recruiting","tldr":"A phase 2 trial of navlimetostat, gemcitabine, nab-paclitaxel and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct04146298","kind":"trial","name":"Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer","route":"/trials/nct04146298/","status":"recruiting","tldr":"A phase 1/2 trial of cyclophosphamide and fludarabine in pancreatic cancer, run by Changhai Hospital, now recruiting."},{"id":"nct06605430","kind":"trial","name":"Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer","route":"/trials/nct06605430/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by HealthPartners Institute, now recruiting."},{"id":"nct05083247","kind":"trial","name":"Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma","route":"/trials/nct05083247/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Erasme University Hospital, now recruiting."},{"id":"nct04570943","kind":"trial","name":"Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","route":"/trials/nct04570943/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Institut du Cancer de Montpellier - Val d'Aurelle, now recruiting."},{"id":"nct07354919","kind":"trial","name":"Axelopran for Advanced Cancer in Patients Receiving Opioids","route":"/trials/nct07354919/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by HealthPartners Institute, now recruiting."},{"id":"nct06770439","kind":"trial","name":"IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer","route":"/trials/nct06770439/","status":"recruiting","tldr":"A phase 2 trial of IBI343, gemcitabine and nab-paclitaxel in pancreatic cancer, run by Zhejiang University, now recruiting."},{"id":"nct06145074","kind":"trial","name":"Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.","route":"/trials/nct06145074/","status":"recruiting","tldr":"A phase 2 trial of propranolol (Hemangeol) in pancreatic cancer, run by Zealand University Hospital, now recruiting."},{"id":"nct06789679","kind":"trial","name":"Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer","route":"/trials/nct06789679/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct05624918","kind":"trial","name":"A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma","route":"/trials/nct05624918/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel, gemcitabine and optune / Optune Pax (TTFields) in pancreatic cancer, run by Ashish Manne, now recruiting."},{"id":"nct06914674","kind":"trial","name":"Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas","route":"/trials/nct06914674/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06690528","kind":"trial","name":"Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver","route":"/trials/nct06690528/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Azienda Ospedaliera di Padova, now recruiting."},{"id":"nct06807437","kind":"trial","name":"Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula","route":"/trials/nct06807437/","status":"recruiting","tldr":"A phase 3 trial of somatostatin analogues (octreotide, lanreotide) in pancreatic cancer, run by SWOG Cancer Research Network, now recruiting."},{"id":"nct06757244","kind":"trial","name":"DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer","route":"/trials/nct06757244/","status":"recruiting","tldr":"A phase 2 trial of dostarlimab in pancreatic cancer, run by Hopital Foch, now recruiting."},{"id":"nct07619521","kind":"trial","name":"Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma","route":"/trials/nct07619521/","status":"recruiting","tldr":"A phase 1/2 trial of selumetinib and trastuzumab deruxtecan in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct06149689","kind":"trial","name":"mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer","route":"/trials/nct06149689/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct05529940","kind":"trial","name":"NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)","route":"/trials/nct05529940/","status":"recruiting","tldr":"A phase 3 trial of fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Seoul National University Hospital, now recruiting."},{"id":"nct05984810","kind":"trial","name":"NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101","route":"/trials/nct05984810/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Leiden University Medical Center, now recruiting."},{"id":"nct06593431","kind":"trial","name":"Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial","route":"/trials/nct06593431/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct05927142","kind":"trial","name":"Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for The","route":"/trials/nct05927142/","status":"recruiting","tldr":"A phase 1/2 trial of durvalumab in pancreatic cancer, run by Joachim Aerts, MD PhD, now recruiting."},{"id":"nct07629609","kind":"trial","name":"BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer","route":"/trials/nct07629609/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Barbara Malene Fischer, now recruiting."},{"id":"nct05720338","kind":"trial","name":"Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?","route":"/trials/nct05720338/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Case Comprehensive Cancer Center, now recruiting."},{"id":"nct06196788","kind":"trial","name":"Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer","route":"/trials/nct06196788/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06454448","kind":"trial","name":"Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic P","route":"/trials/nct06454448/","status":"recruiting","tldr":"A phase 1/2 trial of adebrelimab and decitabine in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting."},{"id":"nct07539155","kind":"trial","name":"Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer","route":"/trials/nct07539155/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by University of Arkansas, now recruiting."},{"id":"nct07126158","kind":"trial","name":"Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","route":"/trials/nct07126158/","status":"recruiting","tldr":"A phase 2 trial of avutometinib + defactinib in pancreatic cancer, run by Washington University School of Medicine, now recruiting."},{"id":"nct07284277","kind":"trial","name":"TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)","route":"/trials/nct07284277/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Clinica Universidad de Navarra, Universidad de Navarra, now recruiting."},{"id":"nct05776524","kind":"trial","name":"Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer","route":"/trials/nct05776524/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by THERABIONIC INC., now recruiting."},{"id":"nct05462496","kind":"trial","name":"Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer","route":"/trials/nct05462496/","status":"recruiting","tldr":"A phase 2 trial of fOLFIRINOX / mFOLFIRINOX and pembrolizumab in pancreatic cancer, run by Icahn School of Medicine at Mount Sinai, now recruiting."},{"id":"nct05241249","kind":"trial","name":"Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma","route":"/trials/nct05241249/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Susan E. Bates, now recruiting."},{"id":"nct04605913","kind":"trial","name":"Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC","route":"/trials/nct04605913/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct06427460","kind":"trial","name":"Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)","route":"/trials/nct06427460/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Changhai Hospital, now recruiting."},{"id":"nct06951997","kind":"trial","name":"QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer","route":"/trials/nct06951997/","status":"recruiting","tldr":"A phase 2 trial of iparomlimab and tuvonralimab, tucidinostat (chidamide), gemcitabine and nab-paclitaxel in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting."},{"id":"nct06761027","kind":"trial","name":"mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer","route":"/trials/nct06761027/","status":"recruiting","tldr":"A phase 1/2 trial of anlotinib and sintilimab in pancreatic cancer, run by Fujian Provincial Hospital, now recruiting."},{"id":"nct03190941","kind":"trial","name":"Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients","route":"/trials/nct03190941/","status":"recruiting","tldr":"A phase 1/2 trial of cyclophosphamide, fludarabine and aldesleukin (high-dose IL-2) in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct07101679","kind":"trial","name":"A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer","route":"/trials/nct07101679/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by West China Hospital, now recruiting."},{"id":"nct06813079","kind":"trial","name":"Using Tumor Models to Determine Treatments","route":"/trials/nct06813079/","status":"recruiting","tldr":"A phase 2 trial of cobimetinib, ponatinib, brigatinib, selinexor and other drugs in pancreatic cancer, run by University Health Network, Toronto, now recruiting."},{"id":"nct04195347","kind":"trial","name":"Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase","route":"/trials/nct04195347/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by St. Jude Children's Research Hospital, now recruiting."},{"id":"nct06747845","kind":"trial","name":"Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy","route":"/trials/nct06747845/","status":"recruiting","tldr":"A phase 2 trial of niraparib and ipilimumab in pancreatic cancer, run by Abramson Cancer Center at Penn Medicine, now recruiting."},{"id":"nct07240766","kind":"trial","name":"HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation","route":"/trials/nct07240766/","status":"recruiting","tldr":"A phase 2 trial of nimotuzumab in pancreatic cancer, run by Zhejiang University, now recruiting."},{"id":"nct06491472","kind":"trial","name":"Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer","route":"/trials/nct06491472/","status":"recruiting","tldr":"A phase 2 trial of ivonescimab, gemcitabine and nab-paclitaxel in pancreatic cancer, run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, now recruiting."},{"id":"nct03755739","kind":"trial","name":"Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors","route":"/trials/nct03755739/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by Second Affiliated Hospital of Guangzhou Medical University, now recruiting."},{"id":"nct06941857","kind":"trial","name":"NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer","route":"/trials/nct06941857/","status":"recruiting","tldr":"A phase 2 trial of cAPOX (capecitabine, oxaliplatin), fOLFIRI (5-FU, leucovorin, irinotecan), leucovorin (folinic acid), fluorouracil (5-FU) and other drugs in pancreatic cancer, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, now recruiting."},{"id":"nct06904378","kind":"trial","name":"ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma","route":"/trials/nct06904378/","status":"recruiting","tldr":"A phase 1/2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Washington University School of Medicine, now recruiting."},{"id":"nct06050317","kind":"trial","name":"Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer","route":"/trials/nct06050317/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Shandong Cancer Hospital and Institute, now recruiting."},{"id":"nct07537660","kind":"trial","name":"Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel","route":"/trials/nct07537660/","status":"recruiting","tldr":"A phase 2 trial of dexamethasone in pancreatic cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting."},{"id":"nct06897644","kind":"trial","name":"Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic C","route":"/trials/nct06897644/","status":"recruiting","tldr":"A phase 3 trial of cAPOX (capecitabine, oxaliplatin), fOLFIRI (5-FU, leucovorin, irinotecan), fLOT (5-FU, leucovorin, oxaliplatin, docetaxel), fluorouracil (5-FU) and other drugs in pancreatic cancer, run by Gruppo Oncologico del Nord-Ovest, now recruiting."},{"id":"nct07214298","kind":"trial","name":"Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma","route":"/trials/nct07214298/","status":"recruiting","tldr":"A phase 1/2 trial of fluorouracil (5-FU), fOLFIRI (5-FU, leucovorin, irinotecan), leucovorin (folinic acid) and cAPOX (capecitabine, oxaliplatin) in pancreatic cancer, run by Roswell Park Cancer Institute, now recruiting."},{"id":"nct02000089","kind":"trial","name":"The Cancer of the Pancreas Screening-5 CAPS5)Study","route":"/trials/nct02000089/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Johns Hopkins University, now recruiting."},{"id":"nct06576115","kind":"trial","name":"Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer","route":"/trials/nct06576115/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Barbara Ann Karmanos Cancer Institute, now recruiting."},{"id":"nct06532617","kind":"trial","name":"Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer","route":"/trials/nct06532617/","status":"recruiting","tldr":"A phase 2 trial of cadonilimab in pancreatic cancer, run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, now recruiting."},{"id":"nct07226856","kind":"trial","name":"BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma","route":"/trials/nct07226856/","status":"recruiting","tldr":"A phase 2 trial of gemcitabine, nab-paclitaxel and nivolumab in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct07257523","kind":"trial","name":"Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer","route":"/trials/nct07257523/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Yonsei University, now recruiting."},{"id":"nct07692750","kind":"trial","name":"IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer","route":"/trials/nct07692750/","status":"recruiting","tldr":"A phase 1/2 trial of IBI343, capecitabine and cAPOX (capecitabine, oxaliplatin) in pancreatic cancer, run by Zhejiang Cancer Hospital, now recruiting."},{"id":"nct06229340","kind":"trial","name":"Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations","route":"/trials/nct06229340/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by N.N. Petrov National Medical Research Center of Oncology, now recruiting."},{"id":"nct06359275","kind":"trial","name":"PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients","route":"/trials/nct06359275/","status":"recruiting","tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06389760","kind":"trial","name":"Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer","route":"/trials/nct06389760/","status":"recruiting","tldr":"A phase 2 trial of nimotuzumab and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, now recruiting."},{"id":"nct05116072","kind":"trial","name":"Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula","route":"/trials/nct05116072/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by University Hospital, Lille, now recruiting."},{"id":"nct06249321","kind":"trial","name":"mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy","route":"/trials/nct06249321/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct06572813","kind":"trial","name":"Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer","route":"/trials/nct06572813/","status":"recruiting","tldr":"A phase 1/2 trial of sintilimab and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by First Affiliated Hospital of Zhejiang University, now recruiting."},{"id":"nct06531278","kind":"trial","name":"Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cance","route":"/trials/nct06531278/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab, cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and leucovorin (folinic acid) in pancreatic cancer, run by Jiang Long, now recruiting."},{"id":"nct03384238","kind":"trial","name":"Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery","route":"/trials/nct03384238/","status":"recruiting","tldr":"A phase 1/2 trial of panitumumab in pancreatic cancer, run by George Poultsides, now recruiting."},{"id":"nct06659705","kind":"trial","name":"Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)","route":"/trials/nct06659705/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by Institut Curie, now recruiting."},{"id":"nct06427447","kind":"trial","name":"Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)","route":"/trials/nct06427447/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Changhai Hospital, now recruiting."},{"id":"nct05132504","kind":"trial","name":"Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer","route":"/trials/nct05132504/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab and fOLFIRINOX / mFOLFIRINOX in pancreatic cancer, run by Baylor College of Medicine, now recruiting."},{"id":"nct06333314","kind":"trial","name":"Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI","route":"/trials/nct06333314/","status":"recruiting","tldr":"A phase 2 trial of dostarlimab in pancreatic cancer, run by UNICANCER, now recruiting."},{"id":"nct04851119","kind":"trial","name":"Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors","route":"/trials/nct04851119/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Children's Oncology Group, now recruiting."},{"id":"nct06547736","kind":"trial","name":"Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer","route":"/trials/nct06547736/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab in pancreatic cancer, run by Fudan University, now recruiting."},{"id":"nct07438106","kind":"trial","name":"A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer","route":"/trials/nct07438106/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, now recruiting."},{"id":"nct07081360","kind":"trial","name":"Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer","route":"/trials/nct07081360/","status":"recruiting","tldr":"A phase 3 trial in pancreatic cancer, run by Minia University, now recruiting."},{"id":"nct02830724","kind":"trial","name":"Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers","route":"/trials/nct02830724/","status":"recruiting","tldr":"A phase 1/2 trial of cyclophosphamide, fludarabine and aldesleukin (high-dose IL-2) in pancreatic cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct07433283","kind":"trial","name":"Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor","route":"/trials/nct07433283/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Sichuan Enray Pharmaceutical Sciences Company, now recruiting."},{"id":"nct04789486","kind":"trial","name":"Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer","route":"/trials/nct04789486/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Dana-Farber Cancer Institute, now recruiting."},{"id":"nct03093688","kind":"trial","name":"Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor","route":"/trials/nct03093688/","status":"recruiting","tldr":"A phase 1/2 trial in pancreatic cancer, run by Shanghai Public Health Clinical Center, now recruiting."},{"id":"nct07586813","kind":"trial","name":"Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors","route":"/trials/nct07586813/","status":"recruiting","tldr":"A phase 2 trial of tretinoin (all-trans retinoic acid, ATRA) in pancreatic cancer, run by Peking University People's Hospital, now recruiting."},{"id":"nct06151262","kind":"trial","name":"A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer","route":"/trials/nct06151262/","status":"recruiting","tldr":"A phase 2 trial in pancreatic cancer, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, now recruiting."},{"id":"nct02598349","kind":"trial","name":"Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas","route":"/trials/nct02598349/","status":"recruiting","tldr":"A phase 2 trial of capecitabine in pancreatic cancer, run by Proton Collaborative Group, now recruiting."},{"id":"nct04858009","kind":"trial","name":"Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis","route":"/trials/nct04858009/","status":"recruiting","tldr":"A phase 2 trial of cisplatin and nab-paclitaxel in pancreatic cancer, run by Mayo Clinic, now recruiting."},{"id":"nct07044453","kind":"trial","name":"Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX","route":"/trials/nct07044453/","status":"recruiting","tldr":"A phase 2/3 trial in pancreatic cancer, run by University Hospital, Rouen, now recruiting."}]}